News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Pfizer New Zealand Affirms Celebrex Safety

1 October 2004

Pfizer New Zealand Affirms Celebrex Safety

In response to patient enquiries about Merck & Co.'s worldwide withdrawal of its COX-2 medicine Vioxx, Pfizer New Zealand has issued an assurance that its anti-arthritis treatment, Celebrex®, is safe.

"Pfizer New Zealand is confident in the long-term cardiovascular safety of Celebrex, based on a large body of clinical evidence,” said Pfizer Australia’s Senior Medical Director, Dr Bill Ketelbey.
”In a recent FDA-sponsored study of 1.4 million patients (Graham et al), those who received Celebrex demonstrated no increased risk of cardiac events.

"Six other very large clinical studies involving over 150,000 patients have shown no increase in cardiac risk with Celebrex compared to background rates.

"The bottom line is that Celebrex is safe, but if patients are confused or have concerns about any treatment they should speak with their doctor.”

Celebrex was the first COX-2 inhibitor, a class of medicine designed to relieve pain without the serious gastrointestinal side effects associated with older non-steroidal anti-inflammatory medicines.

Celebrex (celecoxib) is indicated for symptomatic treatment of osteoarthritis and rheumatoid arthritis, acute pain, for the treatment of primary dysmenorrhoea in adults and for the reduction of adenomatous colorectal polyps in familial adenomatous polyposis (FAP) as an adjunct to usual care, with precautions.

ENDS For further information you can refer to the Medsafe website under Hot Topicscontact or contact Suzanne Booth from Pfizer New Zealand on 0274 844 27, or Dr John Petrie, Rheumatolgist, Queen Elizabeth, on mob. 027 479 7759.

Consumer Mandatories

Celebrex is an unfunded medicine. Doctor fees and a pharmacy charge will apply.

CELEBREX® (celecoxib 100/200mg capsules) is a Prescription Medicine for the treatment of pain and inflammation in osteoarthritis, rheumatoid arthritis, acute pain, and primary dysmenorrhea. Consult your doctor to see if Celebrex is right for you.

You should not take this product if you have had allergic-type reaction or an asthma attack after taking aspirin, sulphonamides or anti-inflammatory medicines. Tell your doctor if you have kidney or liver disease or are pregnant or you have a previous history of stomach ulcers or bleeding. Possible side effects are nausea, dyspepsia, fluid retention, headache and upper respiratory tract infections. U

se strictly as directed. If symptoms continue or you have side effects consult your doctor. For more information on Celebrex® call 0800 003 366 or visit or refer to the consumer medicine information on . Celebrex is a registered trademark of Pfizer New Zealand Ltd PO Box 3998, Auckland Level 3 Pfizer House 14 Normanby Rd, Mt Eden Auckland. Freephone 0800 699 276


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines

Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>

Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>


Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
Jenny Abrahamson's John & Charles Enys: Castle Hill Runholders, 1864-1891

This volume will be of interest to a range of readers interested in the South Island high country, New Zealand’s natural environment, and the history of science. More>>